Tenet Healthcare (NYSE:THC) Director Nadja West Sells 3,000 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 3,000 shares of the business’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $173.45 on Friday. The business’s 50 day simple moving average is $190.50 and its 200 day simple moving average is $202.06. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The stock has a market capitalization of $14.94 billion, a PE ratio of 9.02, a PEG ratio of 1.19 and a beta of 1.30. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating the consensus estimate of $4.21 by $0.61. The business had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm’s revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts forecast that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in THC. WCM Investment Management LLC increased its stake in shares of Tenet Healthcare by 244.4% during the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after buying an additional 362,083 shares during the period. AlphaQuest LLC boosted its position in shares of Tenet Healthcare by 238.3% during the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after purchasing an additional 4,202 shares in the last quarter. Winnow Wealth LLC bought a new stake in shares of Tenet Healthcare during the third quarter valued at approximately $1,129,000. Savant Capital LLC boosted its position in shares of Tenet Healthcare by 27.5% during the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock valued at $3,430,000 after purchasing an additional 3,647 shares in the last quarter. Finally, Caption Management LLC bought a new stake in shares of Tenet Healthcare during the third quarter valued at approximately $5,650,000. Institutional investors own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on THC. Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 11th. Leerink Partners increased their price target on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research report on Friday, February 20th. KeyCorp lowered their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. UBS Group increased their price target on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Finally, Wells Fargo & Company lowered their price target on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $244.16.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.